Interestingly, studies in patients with hepatocellular carcinoma revealed a higher number of IL-17 expressing lymphocytes in tumor tissue [7], which correlates with reduced survival [8], suggesting IL-17 a tumor promoting role. Here, IL17A is linked to neoplasm.